Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ CDC panel adjourns without vote to extend vaccine pause against Johnson & Johnson COVID

CDC panel adjourns without vote to extend vaccine pause against Johnson & Johnson COVID

The Centers for Disease Control and Prevention’s advisory committee did not vote Wednesday on whether to extend the country’s pause against Johnson & Johnson’s COVID-19 vaccine, after experts from the group say there is still not enough data to make final recommendations. in light of the serious, rare clotting events potentially associated with the shots.

While the CDC’s current pause on Johnson and Johnson’s vaccine is not binding, a warning issued by federal health officials on Tuesday urged vaccinations to be suspended only until the commission votes on “updated recommendations”

; for the use of the vaccine. In response to FDA and CDC recommendations on the break, all states and DC and Puerto Rico have chosen to temporarily suspend the vaccine.

The CDC has not yet decided on a date for the resumption of the panel’s discussion on the topic.

“Your opinion today was extremely helpful in helping to inform our work next week,” said Dr. Amanda Cohn, the agency’s appointed federal adviser to the advisory committee.

“To be very honest, I do not want to vote on this issue today,” Dr Beth Bell, a member of the committee and a former CDC infectious disease officer, told the committee.

“I just don’t think that was enough information to make an evidence-based decision. We won’t have all the information, but I think there are some things we can gather relatively quickly, and they all have to do with the benefit balance. of risk, “added Dr. Bell.

Source link